NASDAQ:MNMD 18 October 2025

MindMed’s stock has been on fire, vastly outperforming the broader market in recent weeks. Shares rocketed to a 52-week high of $13.09 on October 14, closing that day at $12.58 on unusually heavy volumets2.tech. After a brief mid-week pullback on profit-takingts2.tech, MNMD roared back by week’s end – closing at $13.65 on Friday, Oct. 17, a one-day gain of +14.6%investing.com. This rally has propelled MindMed to roughly +68% YTD returnsts2.tech, a remarkable run fueled by excitement over the company’s clinical progress. Investor sentiment is clearly bullish. The recent surge has been supported by a string of positive news and a broader risk-on mood in biotech. Notably, MindMed boasts a high base of institutional investors – a Simply Wall St analysis via Yahoo Finance highlighted the “high institutional ownership” as a sign of confidence during the stock’s 25%+ spike in late Septemberts2.tech. Retail traders have also piled in, encouraged by momentum and the promise of psychedelic therapies to transform mental health treatment.

MindMed’s stock has been on fire in recent weeks, vastly outperforming the broader market. Shares rocketed to a 52-week high of $13.09 on October 14, closing that day at $12.58 with unusually heavy trading volumemarketbeat.com. Just a couple of weeks earlier, on September 29, MNMD spiked 12.8% in a single session, hitting ~$12.04 by day’s endallpennystocks.com. These sharp gains have propelled MindMed to roughly +68% year-to-date returnsfinance.yahoo.com, a remarkable run driven by excitement over its clinical progress. Investor sentiment is clearly bullish. The stock’s rally has been supported by positive news and a generally risk-on mood for biotech. Notably, MindMed boasts a large base of committed institutional investors – a Simply Wall St analysis noted the “high institutional ownership” reflects confidence as the stock surged over 25% in a weekfinance.yahoo.com. Many retail traders have also jumped in, encouraged by momentum and the promise of psychedelic therapies to revolutionize mental health treatment.